AlphaLiquid® Detect

AlphaLiquid® Detect

AlphaLiquid®Detect is a tailored liquid biopsy platform for early monitoring of recurrence after cancer surgery.


Negotiable Min Order Quantity Unit

Required Quantity
Place of Origin
South Korea
Payment Terms
T/T
Production method
Available
Shipping / Lead Time
Negotiable / Negotiable
Keyword
cancer diagnostics, minimal residual disease, early detection
Category
Medical Test Kit

IMB Dx, Inc.

Membership
PRO
Country / Year Established
South Korea South Korea / 2018
Business type
Others
Verified Certificate

1

DUNS

Product name AlphaLiquid® Detect Certification -
Category Medical Test Kit Material -
Keyword cancer diagnostics , minimal residual disease , early detection Unit Size -
Brand name - Unit Weigh -
origin South Korea Stock 0
Supply type Available HS code -

Product Information

A personalized liquid biopsy platform is available for early monitoring of cancer recurrence after surgery. This platform detects tumor specific genetic mutations in cancer tissues during surgery, creates personalized gene panels, and performs minimal residual disease (MRD) monitoring after surgery.The test results can guide adjustments in anticancer drug and  treatment progress, ultimately improving the patient's survival rate.

The test detects specific mutations to monitor in the patient's surgical tissue and creates a personalized panel using our algorithm. This personalized panel includes a region where drug resistance mutations can be detected. The patient's blood is targetedly sequenced to determine if the patient has any minimal residual disease. With this bespoke panel, the patient can continuously monitor for recurrence.

AlphaLiquid® Detect is an industry-first personalized, hybrid-capture NGS based liquid biopsy test. This test is designed 
for the detection and surveillance of minimal residual disease (MRD) in patients with stage I-III solid tumors. The assay 
uses a personalized panel of up to 1,000 targets, which includes both patient-specific markers informed by tumor 
analysis and additional therapeutic targets.

B2B Trade

Price (FOB) Negotiable transportation Express
MOQ Negotiable Leadtime Negotiable
Payment Options T/T Shipping time Negotiable

IMB Dx, Inc.

Country / Year Established
South Korea South Korea / 2018
Membership
PRO
Business type
Others

1

DUNS

President
Product Category
Medical Test Kit
Year Established
2018
Main Markets

Japan Japan

Mexico Mexico

U. Kingdom U. Kingdom

U.S.A U.S.A

Main Product

Related Products

Other buyers also search

Membership Grade

BUYER

Biz Pro VIP

SELLER

Biz Pro VIP
팝업닫기
Live Chat A new message arrives
from a business partner.

No Data

  • There is no data to load
  • Check out the My TK > My Inquiries list.
  • After agreeing to the use of the Live Chat service, the list is printed only when there is at least one history of receiving or sending a Live Chat request.

If you have not yet agreed to use the Live Chat service,

You can use the Live Chat freely after agreeing to the use of the Live Chat service.

View more
View more